 Goldman Sachs Group Inc. lowered its holdings in Harpoon Therapeutics Inc NASDAQ:HARP by 48.5 in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,055 shares of the companys stock after selling 10,395 shares during the period. Goldman Sachs Group Inc.s holdings in Harpoon Therapeutics were worth ... 